Cas No.: | 209410-46-8 |
名称: | 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one |
别名: | VX 745,VX745 |
SMILES: | O=C1N=CN(C(C=C2)=C1C3=C(Cl)C=CC=C3Cl)N=C2SC4=CC=C(F)C=C4F |
分子式: | C19H9Cl2F2N3Os |
分子量: | 436.26 |
纯度: | |
保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | |
In Vivo: | |
In Vitro: | |
References: | VX-745 is an antiarthritic Drugs. Its activities and application include: Myelodysplastic Syndrome Therapy, Oncolytic Drugs, Rheumatoid Arthritis, Treatment of, treatment of musculoskeletal & connective tissue diseases, Antiinflammatory Drugs, p38 Protein |
Kinase Assay: | |
Cell Assay: | |
Animal Administration: | |
References: |